NCT05178303View on ClinicalTrials.gov

Composition for Treating Cirrhosis and Liver Cancer (SB-1121)

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 10, 2021

Study Completion Date

November 10, 2021

Conditions
Cirrhosis of the Liver
Interventions
DRUG

SB-1121(1)

The daily maintenance, SB-1121(1) dose is to take 2 times a day, 1 tablet each time.

DRUG

SB-1121(2)

The daily maintenance, SB-1121(2) dose is to take 2 times a day, 1 tablet each time.

Trial Locations (2)

700000

Saigon Biopharma Company Limited, Ho Chi Minh City

19801-6601

Saigon Biopharma LLC, Wilmington

All Listed Sponsors
collaborator

Tran Minh Duc

UNKNOWN

lead

Nguyen Thi Trieu, MD

INDIV

NCT05178303 - Composition for Treating Cirrhosis and Liver Cancer (SB-1121) | Biotech Hunter | Biotech Hunter